While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...

Scientists at a university in the UK are in the midst of creating a breakthrough vaccine that could stop cancer in its tracks ...

While the Novavax and the Sanofi GSK vaccines will not be part of the module, it will look at the circumstances surrounding the Covid-19 jab developed by Valneva. The UK had been due to receive ...

British drugmaker GSK plans to acquire US biotech firm IDRx for $1.15 billion, focusing on innovative tumour treatments. Meanwhile, Moderna cuts sales forecast due to weak vaccine demand, and J&J ...

GSK announced that its monoclonal antibody, Nucala (mepolizumab), has been approved in China for treating adults with chronic rhinosinusitis with nasal polyps (CRSwNP), a condition affecting 30 ...

In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward outlook. Now, management expects 2025 revenue to fall into a range between ...

A possible new coronavirus vaccine candidate produced by Sanofi and GSK (GlaxoSmithKline) that uses the human body’s own antigens to neutralize antibody responses for people who have already ...